loader
Please Wait
Applying Filters...

Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Looking for MolPort-002-163-732? Find Controlled & Modified Release used in MolPort-002-163-732 to address drug delivery challenges on PharmaCompass.

    Product
    Nippon provides high-performance, high-value-added cosmetic, pharmaceutical, and industrial raw materials.
    Nanjing Well is focused on R&D, production & sales of Pharmaceutical Excipients & Synthetic Lubricating base oils.
    Previous
    Next
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 Gangwal Healthcare (5)

    02 BASF (16)

    03 Ideal Cures Pvt Ltd (1)

    04 Sigachi Industries (1)

    filter

    01 Capsule (6)

    02 Granule / Pellet (2)

    03 Softgel Capsule (1)

    04 Tablet (8)

    05 Topical Film (2)

    06 Transdermal Patch (3)

    07 Transdermal patches (1)

    filter

    01 Germany (16)

    02 India (7)

    Close
    4
    refresh Reset Filter
    refreshReset Filter
    Learn More #LearnMore
    price-trend Ask Us

    Gangwal Healthcare

    Contact Supplier
      Virtual BoothGangwal Healthcare is powered by innovation, driving health, wellness & healing.
      Contact Supplier Contact Supplier
      Flag India
      Virtual Booth Virtual Booth
      Digital Content Digital Content

      DICOM-DC® SR300

      PDF Supplier PDF
      URL Supplier Web Content
      LM Application #LearnMore

      Applications:

      DiCOM-DC® SR300 is co-processed excipient with a combination of various rate controlling polymers that act as fillers and binders. SR300 is used in sustained-release formulations.

      Ingredient(s): EthylCellulose, Hydroxypropyl Cellulose, Hydroxypropyl Methylcellulose, Magnesium Stearate, Maize Starch, Microcrystalline Cellulose, Silicon Dioxide, Talc

      Dosage Form: Capsule, Tablet

      Category: Co-Processed Excipients, Controlled & Modified Release, Fillers, Diluents & Binders

      Route of Administration (Grade): Oral
      Pharmacopoeia Reference: In-house

      Technical Specifications: NA

      Gangwal Healthcare DiCOM-DC® SR300

      Iran Expo

      Not Confirmed

      envelop Contact Supplier

      Gangwal Healthcare

      Contact Supplier
        Virtual BoothGangwal Healthcare is powered by innovation, driving health, wellness & healing.
        Contact Supplier Contact Supplier
        Flag India
        Virtual Booth Virtual Booth
        Digital Content Digital Content

        GELLETS-P

        PDF Supplier PDF
        URL Supplier Web Content
        LM Application #LearnMore

        Applications:

        Gellets-P® are Microcrystalline Cellulose based spheres for the manufacturing of pellets. MUPS are important variants of solid oral dosage forms containing pellets (Microgranules) and developing modified release products.

        Ingredient(s): Microcrystalline Cellulose

        Dosage Form: Capsule, Granule / Pellet, Tablet

        Category: Controlled & Modified Release

        Route of Administration (Grade): Oral
        Pharmacopoeia Reference: In-house

        Technical Specifications: NA

        Gangwal Healthcare Gellets-P

        Iran Expo

        Not Confirmed

        envelop Contact Supplier

        BASF

        Contact Supplier
        • FDA
        • EDQM
        Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
        Post an Enquiry Post an Enquiry
        Flag Germany
        Virtual Booth Virtual Booth
        Digital Content Digital Content

        KOLLIDON SR

        PDF Supplier PDF
        URL Supplier Web Content
        LM Application #LearnMore

        Applications:

        For non-erodible matrices using direct compression, Controlled release matrix. Matrix former in transdermal patches and topical films.

        Ingredient(s): Hydrated Silica, Lauryl Sulfate, Polyvinyl Acetate, Povidone

        Dosage Form: Capsule, Tablet, Topical Film, Transdermal Patch

        Category: Controlled & Modified Release, Direct Compression, Granulation

        Route of Administration (Grade): Not Available
        Pharmacopoeia Reference: Ph. Eur., USP-NF, JP-JPE: 80 % Polyvinyl acetate and 19 % povidone, 0.8 % lauryl sulfate & 0.2 % silica (4:1)

        Technical Specifications: Not Available
        ASK
        US
        PHARMACOMPASS
        Upload
        your Marketing & Sales content

        Ideal Cures Pvt Ltd

        Contact Supplier
          Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
          Post an Enquiry Post an Enquiry
          Flag India
          Virtual Booth Virtual Booth
          Digital Content Digital Content

          ESPHERES EM

          PDF Supplier PDF
          URL Supplier Web Content
          LM Application #LearnMore

          Applications:

          These spheres can be used as an inert base for modified release formulations promoting consistency and uniformity of release profile thus ensuring a uniform therapeutic response.

          Ingredient(s): Microcrystalline Cellulose

          Dosage Form: Tablet

          Category: Controlled & Modified Release

          Route of Administration (Grade): Oral
          Pharmacopoeia Reference: Particle Sizes - #20 – #30, #30 – #40 and #40 – #60

          Technical Specifications: Not Available
          ASK
          US
          PHARMACOMPASS
          Upload
          your Marketing & Sales content

          Sigachi Industries

          Contact Supplier
            Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
            Post an Enquiry Post an Enquiry
            Flag India
            Virtual Booth Virtual Booth
            Digital Content Digital Content

            HICEL MCC SPHERES

            PDF Supplier PDF
            URL Supplier Web Content
            LM Application #LearnMore

            Applications:

            HiCel MCC Spheres are extremely versatile which is used for controlled release or sustained release formulations.

            Ingredient(s): Microcrystalline Cellulose

            Dosage Form: Tablet

            Category: Controlled & Modified Release

            Route of Administration (Grade): Oral
            Pharmacopoeia Reference: Not Available

            Technical Specifications: Not Available
            ASK
            US
            PHARMACOMPASS
            Upload
            your Marketing & Sales content

            BASF

            Contact Supplier
            • FDA
            • EDQM
            Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
            Post an Enquiry Post an Enquiry
            Flag Germany
            Virtual Booth Virtual Booth
            Digital Content Digital Content

            KOLLICOAT SR 30 D

            PDF Supplier PDF
            URL Supplier Web Content
            LM Application #LearnMore

            Applications:

            pH-independent sustained release coating for small particles, pellets, granules and tablets. Sprayable polymeric film former. Flexible. Wash resistant.

            Ingredient(s): Polyvinyl Acetate, Sodium Lauryl Sulfate

            Dosage Form: Capsule, Granule / Pellet, Softgel Capsule, Tablet, Topical Film

            Category: Coating Systems & Additives, Controlled & Modified Release, Taste Masking

            Route of Administration (Grade): Not Available
            Pharmacopoeia Reference: Ph. Eur.: Poly(vinyl acetate) dispersion 30 per cent; USP: Polyvinyl Acetate Dispersion

            Technical Specifications: Not Available
            ASK
            US
            PHARMACOMPASS
            Upload
            your Marketing & Sales content

            BASF

            Contact Supplier
            • FDA
            • EDQM
            Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
            Post an Enquiry Post an Enquiry
            Flag Germany
            Virtual Booth Virtual Booth
            Digital Content Digital Content

            KOLLIDON 25

            PDF Supplier PDF
            URL Supplier Web Content
            LM Application #LearnMore

            Applications:

            Solubilization, dispersion, crystallization inhibition, instant release matrices & spray drying

            Ingredient(s): Povidone

            Dosage Form: Capsule, Tablet, Transdermal Patch

            Category: Controlled & Modified Release

            Route of Administration (Grade): Not Available
            Pharmacopoeia Reference: Ph. Eur., USP, JP

            Technical Specifications: Not Available
            ASK
            US
            PHARMACOMPASS
            Upload
            your Marketing & Sales content

            BASF

            Contact Supplier
            • FDA
            • EDQM
            Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
            Post an Enquiry Post an Enquiry
            Flag Germany
            Virtual Booth Virtual Booth
            Digital Content Digital Content

            KOLLIDON 30

            PDF Supplier PDF
            URL Supplier Web Content
            LM Application #LearnMore

            Applications:

            Solubilization, dispersion, crystallization inhibition, instant release matrices & spray drying

            Ingredient(s): Povidone

            Dosage Form: Capsule, Tablet, Transdermal Patch, Transdermal patches

            Category: Controlled & Modified Release, Solubilizers

            Route of Administration (Grade): Not Available
            Pharmacopoeia Reference: Ph. Eur., USP, JP: Povidone

            Technical Specifications: Not Available
            ASK
            US
            PHARMACOMPASS
            Upload
            your Marketing & Sales content
            Post Enquiry
            POST ENQUIRY